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Abstract
Background and Purpose Sleep disordered breathing
(SDB) is frequent in acute stroke patients and is associated
with early neurologic worsening and poor outcome.
Although continuous positive airway pressure (CPAP)
effectively treats SDB, compliance is low. The objective
of the present study was to assess the tolerance and the
efficacy of a continuous high-flow-rate air administered
through an open nasal cannula (transnasal insufflation,
TNI), a less-intrusive method, to treat SDB in acute
stroke patients.
Methods Ten patients (age, 56.8±10.7 years), with SDB
ranging from moderate to severe (apnea–hypopnea
index, AHI, >15/h of sleep) and on a standard sleep
study at a mean of 4.8±3.7 days after ischemic stroke
(range, 1–15 days), were selected. The night after, they
underwent a second sleep study while receiving TNI
(18 L/min).
Results TNI was well tolerated by all patients. For the
entire group, TNI decreased the AHI from 40.4±25.7 to 30.8±
25.7/h (p=0.001) and the oxygen desaturation index >3%
from 40.7±28.4 to 31±22.5/h (p=0.02). All participants
except one showed a decrease in AHI. The percentage of
slow-wave sleep significantly increased with TNI from 16.7±
8.2% to 22.3±7.4% (p=0.01). There was also a trend toward
a reduction in markers of sleep disruption (number of
awakenings, arousal index).
Conclusions TNI improves SDB indices, and possibly
sleep parameters, in stroke patients. Although these changes
are modest, our findings suggest that TNI is a viable
treatment alternative to CPAP in patients with SDB in the
acute phase of ischemic stroke.
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Background
A recent meta-analysis found that sleep disordered breath-
ing (SDB) is present in up to 72% of stroke patients [1].
SDB was primarily obstructive in nature, only 7% of
patients having primarily central apneas. SDB is known to
increase the risk of stroke and stroke risk factors (as
hypertension) [2]. In the acute phase of stroke, when
ischemic penumbra is still present [3], the consequences of
recurrent apneas may have the most deleterious effect on
critically ischemic, but viable, brain tissue. It has been
shown that, in the acute stroke phase, sleep apnea is
associated with early neurologic worsening [4]. The
presence of SDB in stroke patients is also associated with
worse functional outcomes, daily living dependence, a
longer period of hospitalization and rehabilitation [5], and
more psychiatric and behavioral symptoms [6]. Despite the
absence of scientific proof, it is reasonable to assume that
treatment of poststroke SDB may favorably influence
stroke outcome [7]. Furthermore, it may be reasonably
assumed that early treatment may be more effective than
late intervention.
Continuous positive airway pressure (CPAP) is the most
effective and widely used therapy for SDB. However, 25–
50% of patients with SDB will refuse or not tolerate the use
of CPAP therapy [8, 9]. The adherence to CPAP treatment
seems even lower in stroke patients with SDB. With the
exception of some studies performed in the rehabilitation
poststroke setting and in selected patients showing higher
adherence rates [10–12], reported CPAP compliance in the
acute [13–16] and sub-acute stroke phase [12, 17–19] is
around 25–50%. Most patients had stroke-related problems
that caused non-compliance, including facial palsy inducing
CPAP mask leaks [20]. Reasons for discontinuation
treatment also include mask discomfort, difficulty tolerating
pressure, claustrophobia, skin breakdown, inability to apply
headgear, mask, and hose, and to readjust equipment. In
addition, little is known on the effects of CPAP on cerebral
hemodynamics. Data about the effects of CPAP upon
cerebral perfusion are conflicting [21–23], but studies,
performed in healthy volunteers [24] and in acute stroke
patients [16], have shown that CPAP could lead to a
decrease in cerebral blood flow velocity (CBFV). Thus,
there is a clear need for alternative treatments in these
patients.
Transnasal insufflation (TNI) is a less-invasive method
to treat apneas/hypopneas. It delivers warm and humidified
air at a continuous high flow rate through an open nasal
cannula. Treatment with TNI has been shown, in previous
studies, to significantly reduce the apnea–hypopnea index
(AHI) in adults [25, 26] and children [27]. The primary
mechanism of action of TNI appears to be related to small
increases in end-expiratory pharyngeal pressure. The
present study was designed to determine if TNI is well
tolerated in acute stroke patients and whether treatment
with TNI alleviates SDB in these patients.
Materials and methods
Recruitment and demographic characteristics
Participants were recruited from patients admitted for acute
ischemic stroke at the stroke unit of the CHUV (Lausanne,
Switzerland). The study received institutional review board
approval, and after receiving a detailed explanation of the
protocol, each subject signed a written informed consent to
take part in the study. Patients unable to consent due to the
severity of the stroke were excluded. We calculated that we
needed to include ten subjects to have an 80% power to
detect a 5±5-event-per-hour difference on AHI using a
paired t test with an alpha of 0.05.
Study protocol
Patients underwent two consecutive polysomnographies
(PSG) as soon as circumstances allowed it. Night 1 was
used to diagnose the presence of SDB (baseline diagnostic
night: BL). PSG was performed in the hospital room with
titanium recorders and Somnologica biosignal analysis
software (Embla, Broomfield, CO). Signals included
electroencephalograms (F3-A2, F4-A1, C3-A2, C4-A1),
left and right electrooculograms, submental electromyo-
gram, electrocardiogram, oxyhemoglobin saturation, body
position, nasal pressure, and thoracic and abdominal
respiratory movements.
If AHI was >15/h, a second polysomnography with TNI
was performed on the following night (TNI treatment night:
TNI). As previously described [25], TNI consists of an air
compressor (Seleon, Freiburg, Germany) delivering a
constant airflow up to 20 L/min through a nasal cannula.
We chose to apply a flow of 18 L/min for comfort reasons.
A heater and humidifier included in the TNI device
regulated the temperature and humidity. A heated wire
was incorporated into the lumen of the nasal cannula tubing
to achieve a temperature of 30–33°C and relative humidity
of approximately 80% at the nasal outlet.
Analysis
Standard PSG scoring techniques were used to stage sleep
and arousals [28]. Respiratory events were scored accord-
ing to the “Chicago criteria” [29]. An apnea was defined as
complete cessation of airflow for more than 10 s. We
differentiate apneas into obstructive, mixed, or central,
according to the presence or absence of discernable
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excursions of either the chest or abdomen. A hypopnea was
defined as a decrease >50% of airflow from baseline or a
clear amplitude reduction (>30% but <50%) associated
with either an oxygen desaturation of >3% or an arousal.
Respiratory effort-related arousals (RERAs) were identified
as a series of flow-limited breaths that was terminated by an
arousal. An AHI for each individual was calculated, as well
as a respiratory disturbance index (RDI), consisting of the
number of apnea + hypopnea + RERA per hour of sleep.
We also determined an AHI in REM and NREM sleep.
We calculated oxygen desaturation indexes (ODI): ODI3
was defined as the number of 3% desaturation per hour of
sleep, and the ODI4 was defined as the number of 4%
desaturation per hour of sleep. Sleep studies were scored by
a unique, experienced, and registered polysomnographic
technician (DA) and independently reviewed by one of the
authors (JHR).
Statistical analysis
Data are shown as mean and standard deviation, if not
otherwise specified. A paired Student's t test was performed
to compare differences in polysomnographic indices between
BL diagnostic and TNI treatment night. A p value <0.05 was
considered statistically significant. Statistical analyses were
performed with a software program (IBM SPSS Statistics 18,
SPSS Inc., Chicago, IL).
Results
Subject demographics
For this study, we approached 15 patients admitted for acute
ischemic stroke. Five were excluded for analysis after the
BL night: one for technical problems with the PSG
recording, two refused the second PSG, and two had an
AHI <15/h at BL. The remaining ten patients who
completed the study were all men, with a mean age of
56.8±10.7 years. Their median score on the National
Institutes of Health Stroke Scale at admission was 4±4.3
(range 1–13). According to the Oxford Community Stroke
Project classification [30], 3 had partial anterior circulation
infarct, 2 had posterior circulation infarct, and 5 had lacunar
infarct. PSG was performed 4.8±3.7 days after the stroke
symptom onset (range 1–15 days). No patient included in the
study was previously diagnosed for sleep apnea syndrome,
and none of them had ever been treated by CPAP.
Effect of TNI on SDB indices and on sleep variables
TNI was well tolerated by patients with acute stroke:
there were no reports of significant discomfort or side
effects after a full night of treatment with TNI. Overall,
TNI led to a 23.8% reduction in the AHI (40.4±25.7 to
30.8±25.7/h, p=0.001) (Fig. 1). The RDI was also
significantly decreased (41±25.4 vs. 31.4±25.4/h, p=
0.001) (Table 1). TNI decreased the AHI both in REM
(39.8±16.8 vs. 28.7±21.4/h, p=0.048) and NREM sleep
(40.5±28.9 vs. 31±28.9/h, p=0.003).
The ODI3 and the ODI4 both significantly improved
with TNI: 40.7±28.4 vs. 31±22.5/h, p=0.02, and 32.1±
27.7 vs. 22.8±19/h, p=0.04, respectively. No significant
change was observed in the mean oxygen saturation (92.8±
1.6% vs. 93.1±1.8%, p=0.1).
TNI induced heterogeneous response rates among
participants. Noticeable reductions in the AHI were
observed for eight patients, in particular in patients with
moderate SDB. In one of them, the AHI normalized (<5/h).
In one patient with severe SDB, the AHI fell only
minimally from 87.3 to 86.2/h. In one subject, the AHI
was greater with TNI (17.5 vs. 21.4/h).
Sleep structure also improved with TNI. The percentage
of slow-wave sleep (SWS) significantly increased with TNI
(16.7±8.2% vs. 22.3±7.4% of total sleep time, p=0.01).
No changes were noted in the distribution of other sleep
stages. TNI showed a tendency to decrease markers of sleep
disruption, with fewer awakenings (24.5±9.3 vs. 17.9±8.3,
p=0.05), a decreased arousal index (28.9±24.1 vs. 22.4±
22.4/h, p=0.06), and a decreased respiratory arousal index
(23.9±27.6 vs. 17.3±24.5/h, p=0.06). The sleep time
spent in the supine position was similar in both nights
(336.4±41.8 vs. 326.6±89 min, p=0.7).
Discussion
This study was designed to examine the tolerability and the
effect of treatment with TNI on SDB in a series of patients
with acute stroke. TNI was well accepted, and no
significant side effects were reported. Globally, TNI
Fig. 1 AHI during the BL diagnostic and the TNI treatment nights
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significantly lowered the AHI and the ODI and improved
sleep stage distribution with an increase in slow-wave
sleep, but the magnitude of the improvement was rather
modest.
In a previous study, McGinley et al. assessed the efficacy
of TNI in 11 selected subjects with mild to severe
obstructive apnea–hypopnea syndrome [25]. TNI led to a
mean reduction of 63.2% in the overall AHI (28±5 to 10±
3/h), and some improvement of the AHI was observed in
each subject. Recently, in a larger study, Nilius et al. studied
56 patients with a wide spectrum of disease severity [26].
TNI decreased the RDI from 22.6±15.6 to 17.2±13.2
events/h, thus a 31% mean reduction of the RDI, which is
closer to our results. Although TNI decreased RDI in the
majority of patients, some demonstrated a marked increase
in the RDI. In our study, we obtained a mean global
reduction of 23.8% of the AHI. We also found
heterogeneous response rates between patients. In one
subject with moderate SDB, the AHI even increased in
the night with TNI (17.5 vs. 21.4/h), and in one patient
with severe SDB, the AHI fell only minimally. Com-
pared with the previous populations studied, our patients
were older (57.1±11.3 years) and, overall, had a more
severe SDB (AHI 44.5±25.3/h). We used a slightly
lower flow rate of 18 L/min (vs. 20 L/min in previous
studies) to guarantee a maximum of comfort.
We observed that the effect of TNI on respiratory events
was modest in most patients. Nasal CPAP is very likely to
be more efficacious in reducing the AHI. However, CPAP is
often not well tolerated, in particular in the acute phase of
stroke. In addition, CPAP is known to increase intrathoracic
pressure and therefore potentially could increase central
venous and intracranial pressure and reduce cardiac output
[31–33]. The anxiety induced by the sensation of breathing
against a positive pressure could induce hyperventilation
and hypocapnia and, in turn, increase cerebrovascular
resistance. Moreover, studies performed in healthy
volunteers [24] and in acute stroke patients [16] have
shown that CPAP could lead to a decrease in CBFV, as
measured by transcranial doppler. The negative conse-
quences of a fall in CBFV may outweigh the therapeutic
benefits of CPAP in the poststroke settings.
We thus believe that TNI offers a simplified nasal
interface for delivering relatively low levels of pharyngeal
pressure. Additionally, TNI does not require titration. TNI
could be an alternative treatment of SDB when the use of
CPAP is not feasible. The main question is whether the
relatively modest AHI reduction with TNI will have a
clinically significant effect on short- and long-term out-
comes. In some clinical circumstances, even small
decreases in SDB severity have had a profound clinical
impact: Redline et al., analyzing data from a large
prospective cohort of middle-aged and older adults,
recently confirmed that OSA increases risk of first-time
ischemic stroke, in particular in men [34]. In this
population, the risk of stroke increased by 6% with every
unit increase in baseline AHI from 5 to 25/h.
Moreover, the impact of treating SDB in the acute stroke
phase, when cerebral tissue perfusion is seriously compro-
mised, could be particularly important: apneas in the acute
stroke phase have been associated with early neurologic
worsening [4], and it has been shown that the presence of
SDB in stroke patients is associated with worse functional
outcomes [5, 6, 12]. Two studies have demonstrated
reductions in cerebral tissue hemoglobin saturation levels
with apneas [35, 36]. The severity of tissue deoxygenation
correlated with the length of the respiratory disturbance
events and the degree of related desaturation. Respiratory
events also induce marked hemodynamic changes. At the
onset of apnea, there is hypotension and progressive
bradycardia, followed by abrupt tachycardia on resumption
of breathing [37]. These changes are associated with large
fluctuations in CBFV [38, 39]. The repeated hemodynamic
Table 1 Indices of SDB and sleep characteristics
BL diagnostic
night
TNI treatment
night
p value
TST, min 419.4±43 410.3±95.1 0.77
TST in supine position, min 336.4±41.8 326.6±86.8 0.76
Sleep efficiency, % 81±8 77±13 0.31
Stage 1, % 19.6±12.1 14.4±4.8 0.13
Stage 2, % 43.8±6.2 42.3±7.7 0.63
SWS, % 16.7±8.2 22.3±7.4 0.01
REM, % 19.7±6 20.8±5.4 0.71
WASO, min 100.3±43.1 118.9±61.4 0.33
Awakenings, nr 24.5±9.3 17.9±8.3 0.05
Arousal index, nr/h 28.9±24.1 22.4±22.4 0.06
Respiratory arousal
index, nr/h
23.9±27.1 17.3±24.5 0.06
AHI, nr/h 40.4±25.7 30.8±25.7 0.001
OAI, nr/h 8.6±8.6 4.9±4.9 0.08
CAI, nr/h 2±3.1 3.3±4 0.16
MAI, nr/h 8.2±13 3.5±5.7 0.1
HI, nr/h 23.8±16.2 19.2±18.2 0.26
RDI, nr/h 41±25.4 31.4±25.4 0.001
AHI NREM, nr/h 40.5±28.9 31±28.9 0.003
AHI REM, nr/h 39.8±16.8 28.7±21.4 0.04
Mean SpO2, % 92.8±1.6 93.1±1.8 0.16
ODI >3%, nr/h 40.7±28.4 31±22.5 0.02
ODI >4%, nr/h 32.1±27.7 22.8±19 0.04
TST total sleep time, SWS slow-wave sleep, REM rapid eye movement,
WASO wake after sleep onset, AHI apnea/hypopnea index, OAI
obstructive apnea index, CAI central apnea index, MAI mixed apnea
index, HI hypopnea index, RDI respiratory disturbance index, SpO2
oxygen saturation index, ODI oxygen desaturation index
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oscillations that accompany both occlusion of the upper
airway and the post-apneic phase may have a deleterious
effect in the penumbra zone. Reducing the AHI, even
mildly, may have a positive effect on tissue survival after
stroke.
There are several limitations to the current study. First of
all, only a limited number of patients were included in this
preliminary study and makes its generalizability to all
stroke patients questionable. Also, only male patients were
recruited. Because of the small number of patients studied,
it is not possible to determine demographic or polysomno-
graphic predictors for treatment responses. TNI was used
for only one night, and further studies of TNI administered
over several nights would be required to examine its long-
term effects. We used a fixed relatively low flow rate of
18 L/min, determined empirically (no titration) to guarantee
a maximum of comfort of TNI. We could speculate that a
higher flow rate could yield better results. Since the order
of baseline and TNI nights were not randomized, one could
argue that the observed therapeutic effects of TNI may be
attributed to the expected spontaneous decrease of apneas
as stroke recovery progresses. The response rate to TNI was
almost twofold as high as the expected night-to-night
variability in sleep apnea severity of 13% [40]; however,
randomizing TNI nights was beyond the scope of the
current study. As patients were studied in the acute phase of
stroke, they spent most of the night in the supine position
(around 80% of the total sleep time, TST). This could be
another factor responsible for the modest effects of the
treatment: the supine position increases the severity of
respiratory events, counteracting the expected improvement
of treatment, if TNI does not act as a mechanical splint
(as CPAP or oral devices) but by means of a functional
increase of the expiratory pharyngeal pressure.
In summary, this preliminary study provides evidence
that TNI is a viable alternative treatment, when CPAP is not
tolerated or not indicated, in patients with SDB in the acute
phase of ischemic stroke and induces a significant reduction
in AHI in these patients. Further studies will be required to
confirm these findings and to determine the effect of TNI in
long-term outcome of stroke patients.
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